Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2238-2252
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2238
Figure 3
Figure 3 Alternation trends in combined diagnosis, age, and constituent ratio according to the anatomical subsite of gastric cancer during the study period. A: Percentage change in cardia cancer along with the complication of gastroesophageal reflux disease; B: Percentage change in gastric antrum cancer along with the complication of Helicoibacter pylori (H. pylori) infection-related diseases; C: Age changes among patients with cardia cancer aged 50-74 years, after stratification of patients into five age subgroups; D: Age changes among patients with non-cardia cancer aged 50-74 years, after stratification into five age subgroups. GERD: Gastroesophageal reflux disease; HIRD: H. pylori infection-related diseases.